Company / Cash per Share
RECURSION PHARMACEUTICALS, INC. Cash per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.87
FY2025
5-year range
$1.87 / $12.78
FY2021-FY2025
Trend
-26.2%
vs FY2024
Sector context
#112 of 205
Health Care
What the data says
At $1.87, RECURSION PHARMACEUTICALS, INC.'s cash per share ranks #112 of 205 in the Health Care sector. Cash per Share has fluctuated over the past 6 years, ranging from $1.87 in FY2025 to $12.78 in FY2021.
Based on SEC 10-K filings.
1.87 in FY2025 with a 5-year CAGR of -31.1%.
Declined from $2.05 to $1.87 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -16.6%
- 5-Year CAGR
- -31.1%
- 10-Year CAGR
- -
Sector benchmark
#112 of 205 in Health CareTop 55% of 205This company $1.87 Sector average $67.98
▼
-97.2% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 26.2% year-over-year.
- Ranks #112 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.80 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.87 | -26.2% |
| FY2024 | $2.54 | +23.8% |
| FY2023 | $2.05 | -36.5% |
| FY2022 | $3.23 | -74.7% |
| FY2021 | $12.78 | +6.2% |
| FY2020 | $12.03 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026